Riassunto
Il Phosfon D, composto ritardante la crescita nelle piante superiori, induce la comparsa di pigmenti chinonici in un ceppo incolore del fungo dermato fitaTrichophyton mentagrophytes. Viene ipotizzato che il Phosfon D dereprima i geni per gli enzimi catalizzanti la sintesi dei pigmenti neoformati.
Literatur
P. Tate, Biol. Rev.4, 41 (1929).
K. W. Thompson, Rep. Conf. on Dermatophytes, Div. Med. Sci. natn. Res. Council, Nov. 8 (1943).
P. Pinetti, Rass. med. sarda7–8, 1 (1949).
G. Rebell andD. Taplin,Dermatophytes (Miami Univ. Press, Coral Gables, Florida 1970).
J. C. Wirth, P. J. O'Brien, F. L. Schmitt andA. Sohler, J. invest. Derm.29, 47 (1957).
P. D. Mier, Nature, Lond.179, 1084 (1957).
M. G. McCabe andP. D. Mier, J. gen. Microbiol.23, 1 (1960).
W. G. Koehne, F. T. Wolf andE. A. Jones, J. invest. Derm.39, 189 (1962).
G. Just, W. C. Day andF. Blank, Can. J. Chem.41, 74 (1963).
Y. Ito, T. Fujii andY. Nozawa J. invest. Derm.42, 175 (1964).
Y. Ito, T. Fujii, Y. Nozawa andA. Takeyama, J. invest. Derm.44, 345 (1965).
Y. Ito, Y. Nozawa andT. Yoneya, J. Chromat.35, 573 (1968).
Phosfon D (Virginia-Carolina Chemical Corporation, Richmond, Virginia, USA) is a chemical commonly employed for retarding growth in higher plants. The compound has been shown to inhibit the gibberellic acid synthetic pathway both in higher plants and in gibberellic acid producing fungi (seeWest andFall 14 for additional details).
C. A. West andR. R. Fall,Plant Growth Substances 1970 (Ed.D. J. Carr; Springer-Verlag, Berlin 1972), p. 133.
J. W. Carmichael, Mycologia48, 450 (1956).
E. L. Tatum, A. Rev. Biochem.13, 667 (1944).
J. H. Birkinshaw, A. Rev. Biochem.22, 371 (1953).
C. E. Stickings andH. Raistrick, A. Rev. Biochem.25, 225 (1956).
Author information
Authors and Affiliations
Additional information
The authors are indebted to Prof.F. Conconi for helpful discussion.
Rights and permissions
About this article
Cite this article
Vannini, G.L., Dall'olio, G. & Bonora, A. Pigment formation in a colourless strain ofTrichophyton mentagrophytes after phosfon D treatment. Experientia 30, 203–205 (1974). https://doi.org/10.1007/BF01927736
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01927736